FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rene Gonzalez

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Anatomy

Circulating Neoplastic Cells

Co-author Network

Publications

TOP 3
Yuchun Luo; Martin D McCarter; David A Norris; Steven E Robinson; William A Robinson; Dennis R Roop; David C Thompson; Vasilis Vasiliou; Jianbin Wang; Ying Chen; Katiuscia Dallaglio; Rene Gonzalez; Mayumi Fujita
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Yuchun Luo; Martin D McCarter; David A Norris; Steven E Robinson; William A Robinson; Dennis R Roop; Richard A Spritz; Moe Takeda; Natalie G Ahn; Katiuscia Dallaglio; Lixia Z Ellis; Rene Gonzalez; Karl D Lewis; Weimin Liu; Mayumi Fujita
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.
Nicole Kounalakis; Karl Lewis; Maude Becker; Dexiang Gao; Rene Gonzalez; Nathan W Pearlman; Jamie Poust; William Robinson; Martin McCarter
A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rene Gonzalez (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yuchun Luo; Martin D McCarter; David A Norris; Steven E Robinson; William A Robinson; Dennis R Roop; David C Thompson; Vasilis Vasiliou; Jianbin Wang; Ying Chen; Katiuscia Dallaglio; Rene Gonzalez; Mayumi Fujita
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.
Stem cells (Dayton, Ohio) 2012;30(10):2100-13.
2012: Yuchun Luo; Martin D McCarter; David A Norris; Steven E Robinson; William A Robinson; Dennis R Roop; Richard A Spritz; Moe Takeda; Natalie G Ahn; Katiuscia Dallaglio; Lixia Z Ellis; Rene Gonzalez; Karl D Lewis; Weimin Liu; Mayumi Fujita
Side population cells from human melanoma tumors reveal diverse mechanisms for chemoresistance.
The Journal of investigative dermatology 2012;132(10):2440-50.
2012: Nicole Kounalakis; Karl Lewis; Maude Becker; Dexiang Gao; Rene Gonzalez; Nathan W Pearlman; Jamie Poust; William Robinson; Martin McCarter
A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes.
Immunotherapy 2012;4(7):679-86.
2012: Steven N Reuland; Shilo Smith; Mayumi Fujita; Nathaniel Goldstein; Rene Gonzalez; Karl Lewis; Yuchun Luo; David A Norris; Katie A Partyka; Yiqun G Shellman
ABT-737 synergizes with Bortezomib to kill melanoma cells.
Biology open 2012;1(2):92-100.
2011: Rodabe N Amaria; Karl D Lewis; Rene Gonzalez
Therapeutic options in cutaneous melanoma: latest developments.
Therapeutic advances in medical oncology 2011;3(5):245-51.
2011: Karl D Lewis; Wolfram Samlowski; John Ward; Joseph Catlett; Lee Cranmer; John Kirkwood; David Lawson; Eric Whitman; Rene Gonzalez
A multi-center phase II evaluation of the small molecule survivin suppressor YM155 in patients with unresectable stage III or IV melanoma.
Investigational new drugs 2011;29(1):161-6.
2011: Michelle A Stinauer; Brian D Kavanagh; Tracey E Schefter; Rene Gonzalez; Thomas Flaig; Karl Lewis; William Robinson; Mark Chidel; Michael Glode; David Raben
Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control.
Radiation oncology (London, England) 2011;6():34.
2011: Rozina Chowdhery; Rene Gonzalez
Immunologic therapy targeting metastatic melanoma: allovectin-7.
Immunotherapy 2011;3(1):17-21.
2010: Kazuo Koyanagi; Steven J O'Day; Peter D Boasberg; Michael B Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A Thompson; Clay M Anderson; Jose Lutzky; Thomas T Amatruda; Evan M Hersh; Jon Richards; Jeffrey S Weber; Dave S B Hoon
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2402-8.
2010: Sonia Okuyama; Rene Gonzalez; Karl D Lewis
Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review.
Core evidence 2010;5():39-48.
2009: Joel M Baumgartner; Rene Gonzalez; Karl D Lewis; William A Robinson; Don A Richter; Brent E Palmer; Cara C Wilson; Martin D McCarter
Increased survival from stage IV melanoma associated with fewer regulatory T Cells.
The Journal of surgical research 2009;154(1):13-20.
2009: Mayumi Fujita; Whitney A High; Shabnam Asgari; Karl D Lewis; Rene Gonzalez
Development of vitiligo during melanoma treatment with a novel survivin inhibitor: a case report and review of the literature.
International journal of dermatology 2009;48(4):426-30.
2008: Ragini Kudchadkar; Rene Gonzalez; Karl D Lewis
PI-88: a novel inhibitor of angiogenesis.
Expert opinion on investigational drugs 2008;17(11):1769-76.
2008: Ragini Kudchadkar; Rene Gonzalez; Karl Lewis; Krista Treichel; Susan Hammerman; William A Robinson; James Fitzpatrick; Ricardo Gonzalez; Brian D Kavanagh; Kyle Rusthoven
A case of Merkel cell carcinoma.
Oncology (Williston Park, N.Y.) 2008;22(3):322-8.
2008: Karl D Lewis; William A Robinson; Michael J Millward; Alex Powell; Timothy J Price; Damien B Thomson; Euan T Walpole; Andrew M Haydon; Brian R Creese; Kaye L Roberts; John R Zalcberg; Rene Gonzalez
A phase II study of the heparanase inhibitor PI-88 in patients with advanced melanoma.
Investigational new drugs 2008;26(1):89-94.
2007: Martin D McCarter; Joel Baumgartner; Guillermo Escobar; Donald Richter; Karl Lewis; William A Robinson; Cara Wilson; Brent E Palmer; Rene Gonzalez
Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
Annals of surgical oncology 2007;14(10):2854-60.
2007: Guillermo Escobar; William A Robinson; Trevor L Nydam; Drew C Heiple; Glen J Weiss; Linda Buckley; Rene Gonzalez; Martin D McCarter
Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report.
BMC cancer 2007;7():13.
2006: Nathan W Pearlman; Martin D McCarter; Matthew Frank; Cheryl Hurtubis; Ryan P Merkow; Wilbur A Franklin; Rene Gonzalez; Karl Lewis; J Brent Roaten; William A Robinson
Size of sentinel node metastases predicts other nodal disease and survival in malignant melanoma.
American journal of surgery 2006;192(6):878-81.
2006: Rene Gonzalez; Laura Hutchins; John Nemunaitis; Michael Atkins; Paul Schwarzenberger
Phase 2 trial of Allovectin-7 in advanced metastatic melanoma.
Melanoma research 2006;16(6):521-6.
2006: Larisa Ravdel; William A Robinson; Karl Lewis; Rene Gonzalez
Metastatic melanoma in the breast: a report of 27 cases.
Journal of surgical oncology 2006;94(2):101-4.
2006: Karl D Lewis; William A Robinson; Martin D McCarter; Nathan W Pearlman; Steven J O'Day; Clay Anderson; Thomas T Amatruda; Anna Baron; Chan Zeng; Maude Becker; Susan Dollarhide; Karen Matijevich; Rene Gonzalez
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3157-63.
2006: Karl D Lewis; Susan Dollarhide; James E Fitzpatrick; Rene Gonzalez; Whitney A High; Martin D McCarter; Christine Olsen; David Raben
Metastatic malignant melanoma from an unknown primary presenting as a large axillary mass.
Oncology (Williston Park, N.Y.) 2006;20(7):763-70.
2006: William Qutub; Karl Lewis; Rene Gonzalez; Robert Quaife; Paul Russ; Martin D McCarter
Lymphangiomatosis masquerading as metastatic melanoma.
The American surgeon 2006;72(4):367-70.
2006: Kazuo Koyanagi; Steven J O'Day; Rene Gonzalez; Karl Lewis; William A Robinson; Thomas T Amatruda; Christine Kuo; He-Jing Wang; Robert Milford; Donald L Morton; Dave S B Hoon
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1137-43.
2006: Karl D Lewis; John A Thompson; Jeffrey S Weber; William A Robinson; Steven J O'Day; Jose Lutzky; Sewa S Legha; Simon Floret; Francis Ruvuna; Rene Gonzalez
A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.
Investigational new drugs 2006;24(1):89-94.
2005: Kazuo Koyanagi; Steven J O'Day; Rene Gonzalez; Karl Lewis; William A Robinson; Thomas T Amatruda; He-Jing Wang; Robert Elashoff; Hiroya Takeuchi; Naoyuki Umetani; Dave S B Hoon
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8057-64.
2005: J Brent Roaten; David A Partrick; Denis D Bensard; Nathan W Pearlman; Rene Gonzalez; James Fitzpatrick; Martin D McCarter
Survival in sentinel lymph node-positive pediatric melanoma.
Journal of pediatric surgery 2005;40(6):988-92; discussion 992.
2005: Karl D Lewis; Peter Gibbs; Steven J O'Day; Jon Richards; Jeffrey Weber; Clay Anderson; Chan Zeng; Anna Baron; Paul Russ; Rene Gonzalez
A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.
Cancer investigation 2005;23(4):303-8.
2005: J Brent Roaten; David A Partrick; Nathan W Pearlman; Ricardo J Gonzalez; Rene Gonzalez; Martin D McCarter
Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.
Journal of pediatric surgery 2005;40(1):232-5.
2005: J Brent Roaten; Nathan W Pearlman; Rene Gonzalez; Rene Gonzalez; Martin D McCarter
Identifying risk factors for complications following sentinel lymph node biopsy for melanoma.
Archives of surgery (Chicago, Ill. : 1960) 2005;140(1):85-9.
2004: Karl D Lewis; Rene Gonzalez; William A Robinson; James E Fitzpatrick; Martin D McCarter; Cynthia Braden
A young woman with melanoma diagnosed during pregnancy.
Oncology (Williston Park, N.Y.) 2004;18(7):794-9.
2001: P Gibbs; William A Robinson; Nathan W Pearlman; D Raben; P Walsh; Rene Gonzalez
Management of primary cutaneous melanoma of the head and neck: The University of Colorado experience and a review of the literature.
Journal of surgical oncology 2001;77(3):179-85; discussion 186-7.
2001: P Gibbs; Benjamin M R Brady; Rene Gonzalez; William A Robinson
Nevi and melanoma: lessons from Turner's syndrome.
Dermatology (Basel, Switzerland) 2001;202(1):1-3.
2000: P Gibbs; A Moore; William A Robinson; Patrick Walsh; Loren E Golitz; Rene Gonzalez
Pediatric melanoma: are recent advances in the management of adult melanoma relevant to the pediatric population.
Journal of pediatric hematology/oncology 2000;22(5):428-32.
2000: P Gibbs; A Iannucci; M Becker; J Allen; M O'Driscoll; K McDowell; P Williams; P Rosse; James Murphy; Rene Gonzalez
A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma.
Melanoma research 2000;10(2):171-9.
1999: Rene Gonzalez; S Ebbinghaus; Thomas K Henthorn; D Miller; Andrew Kraft
Treatment of patients with metastatic melanoma with bryostatin-1--a phase II study.
Melanoma research 1999;9(6):599-606.